Always confirm this approach with your provider
Perfect, J
Both Semaglutide GLP-1 and Zepbound are intended for long-term usage in medical weight management
Pediatric patients aged 12 years and older treated with Wegovy had greater incidences of cholelithiasis, cholecystitis, hypotension, rash, and urticaria compared to adults treated with Wegovy 1 There are insufficient data in pediatric patients with type 2 diabetes treated with Wegovy for obesity to determine if there is an increased risk of hypoglycemia with Wegovy treatment similar to that reported in adults
Before administering insulin, it is crucial to clean the injection site to reduce the risk of infection
Patients with pre-existing gastrointestinal conditions, including GERD, peptic ulcer disease, or gastroparesis, should have closer monitoring during GLP-1 initiation and dose escalation